US Patent Application 20100055130 - STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS
InventorsAssigneeUS Classes424/209.1, Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.)530/350, PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI424/234.1, Bacterium or component thereof or substance produced by said bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, etc.)424/243.1, Staphylococcus (e.g., Staphylococcus aureus, etc.)424/263.1, Chlamydia (e.g., Chlamydia trachomatis, etc.)424/254.1, Bordetella pertussis424/244.1, Streptococcus (e.g., Group B Streptococcus, pneumococcus or Streptococcus pneumoniae, etc.)536/23.1, DNA or RNA fragments or modified forms thereof (e.g., genes, etc.)436/536INVOLVING IMMUNE COMPLEX FORMED IN LIQUID PHASEAttorney, Agent or FirmForeign Documents
International ClassesA61K 39/145C07K 14/00 A61K 38/16 A61K 39/085 A61K 39/118 A61K 39/10 A61K 39/09 A61K 39/02 C07H 21/00 G01N 33/536 A61P 37/04 A61P 31/04 A61P 31/12 Abstract textThe invention provides proteins from Staphylococcus aureus, including amino acid sequences and corresponding nucleotide sequences. The proteins are useful for vaccines, immunogenic compositions, diagnostics, enzymatic studies, and as targets for antibiotics. |
| ||||||||||||||
